<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8E89FC72-B2F9-42C4-B495-7361EEA47F78"><gtr:id>8E89FC72-B2F9-42C4-B495-7361EEA47F78</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>George</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/53133DF3-B70B-4195-B6E2-B3F502743FBA"><gtr:id>53133DF3-B70B-4195-B6E2-B3F502743FBA</gtr:id><gtr:firstName>Daqing</gtr:firstName><gtr:surname>Ma</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/67E494A8-94DC-4AB1-AE72-709A89DC0F43"><gtr:id>67E494A8-94DC-4AB1-AE72-709A89DC0F43</gtr:id><gtr:firstName>Mervyn</gtr:firstName><gtr:surname>Maze</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FC381D2E-B59F-4997-BF2B-D435B2966717"><gtr:id>FC381D2E-B59F-4997-BF2B-D435B2966717</gtr:id><gtr:firstName>Patrick</gtr:firstName><gtr:otherNames>H</gtr:otherNames><gtr:surname>Maxwell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F26612C6-66DE-4431-8EA1-59177A1B5570"><gtr:id>F26612C6-66DE-4431-8EA1-59177A1B5570</gtr:id><gtr:firstName>Catherine</gtr:firstName><gtr:otherNames>Jane</gtr:otherNames><gtr:surname>Tralau Stewart</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802392"><gtr:id>7E259C2B-470D-44B9-A0DD-A31A698D9AB8</gtr:id><gtr:title>Improved function and survival of the transplanted kidney by treatment with xenon</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802392</gtr:grantReference><gtr:abstractText>Kidney transplantation is the most cost-effective therapy for end-stage renal disease. Despite considerable advances in immunosuppression and in short-term graft survival, little improvement has been observed in long-term survival rates. In 2007, 6200 patients were on the waiting list for kidney transplantation. Donor organs are therefore highly precious resources, and any intervention that reduces graft failure would be of enormous benefit. Nevertheless, early dysfunction or primary non-function is still seen in up to 50% of grafts from cadaveric donors and about 10% from live donors; these early failures are largely due to injury caused by blood supply being interrupted during cold preservation and warm revascularization of the graft. On the other hand, this injury may also play an important role in the development of chronic graft rejection and late graft loss. We will develop a therapeutic strategy that protects against the injury through a unique mechanism and thereby improves the survival and function of the transplanted kidney. Prevention or reduction of injury could both prevent graft failure and also allow prolonged storage of organs, thus improving donor allocation. If our strategy protects against the injury through a unique mechanism and thereby improve the survival and function of the transplanted kidney, this can be rapidly exploited in the clinical setting. While our therapeutic strategy is confined to renal transplantation, the clinical utility extends to all organ transplantation in which injury impairs graft function.</gtr:abstractText><gtr:technicalSummary>Kidney transplantation is a cost-effective intervention for the treatment of end-stage renal failure. However, ischaemia/reperfusion injury (IRI), as a consequence of prolonged ischaemia (during cold preservation) followed by warm revascularization of the graft, can result in primary dysfunction of the transplanted graft; IRI can also predispose the graft to immunological graft rejection. Thus, interventions to prevent IRI will have a large effect in reducing renal graft failure. We have shown that xenon, the noble anaesthetic gas, either alone or in combination with hypothermia, protects against organ injury (including the kidney) induced by ischaemia/reperfusion when administered before, during and after insults. Our patented finding reveals that the mechanism involves increased translation of Hypoxia Inducible Factor (HIF) 1alpha together with increased expression of proteins of genes with a promoter region containing HIF; we anticipate that xenon will protect against IRI that accompanies renal transplantation through this same mechanism. We propose to explore whether xenon improves the function and survival of a transplanted kidney when administered to the donor before harvesting of the kidney, to the graft during cold ex vivo preservation, and to the recipient after implantation.</gtr:technicalSummary><gtr:fund><gtr:end>2011-11-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>288624</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CAFDF8EF-8A7A-4377-B67C-DD9B7E80295C</gtr:id><gtr:title>Early treatment with xenon protects against the cold ischemia associated with chronic allograft nephropathy in rats.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/965fa2e737474be04198ec1e700c3e4c"><gtr:id>965fa2e737474be04198ec1e700c3e4c</gtr:id><gtr:otherNames>Zhao H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn><gtr:outcomeId>doi_15744_i_2013_334</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F90EECCF-4A0C-431A-A3DE-D58606F679FA</gtr:id><gtr:title>Xenon Treatment Protects against Remote Lung Injury after Kidney Transplantation in Rats.</gtr:title><gtr:parentPublicationTitle>Anesthesiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/965fa2e737474be04198ec1e700c3e4c"><gtr:id>965fa2e737474be04198ec1e700c3e4c</gtr:id><gtr:otherNames>Zhao H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0003-3022</gtr:issn><gtr:outcomeId>58c804f4e11f27.76251232</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E256490-2B4A-4700-B952-FEC5354D905B</gtr:id><gtr:title>Cellular signaling pathways and molecular mechanisms involving inhalational anesthetics-induced organoprotection.</gtr:title><gtr:parentPublicationTitle>Journal of anesthesia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/688c724f0634d353269671f0a3751196"><gtr:id>688c724f0634d353269671f0a3751196</gtr:id><gtr:otherNames>Wu L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0913-8668</gtr:issn><gtr:outcomeId>58c806a18b6299.35504692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>239979BC-E991-42F9-9545-B059E8BE5C37</gtr:id><gtr:title>Benzodiazepine augmented ?-amino-butyric acid signaling increases mortality from pneumonia in mice.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2e5b1ee3098b90568bcaf68ba8fb2f9"><gtr:id>f2e5b1ee3098b90568bcaf68ba8fb2f9</gtr:id><gtr:otherNames>Sanders RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn><gtr:outcomeId>pm_540e166e1663d5db4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E8A2AF5-77A4-49A3-AD55-3BDF32328342</gtr:id><gtr:title>Xenon treatment attenuates early renal allograft injury associated with prolonged hypothermic storage in rats.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/965fa2e737474be04198ec1e700c3e4c"><gtr:id>965fa2e737474be04198ec1e700c3e4c</gtr:id><gtr:otherNames>Zhao H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>doi_15744__13_232173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B4F6A44-01BE-411F-A423-D82D1FB5663C</gtr:id><gtr:title>Necroptosis and parthanatos are involved in remote lung injury after receiving ischemic renal allografts in rats.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/965fa2e737474be04198ec1e700c3e4c"><gtr:id>965fa2e737474be04198ec1e700c3e4c</gtr:id><gtr:otherNames>Zhao H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn><gtr:outcomeId>5461f3963ccd69.92283206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA534FB9-E5A8-46C4-B70D-C0D2F7123990</gtr:id><gtr:title>Xenon treatment protects against cold ischemia associated delayed graft function and prolongs graft survival in rats.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/965fa2e737474be04198ec1e700c3e4c"><gtr:id>965fa2e737474be04198ec1e700c3e4c</gtr:id><gtr:otherNames>Zhao H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>doi_15744__ajt_12293</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>163C10ED-0E0C-41FB-83E7-8128C9C05F52</gtr:id><gtr:title>A novel strategy for preserving renal grafts in an ex vivo setting: potential for enhancing the marginal donor pool.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/965fa2e737474be04198ec1e700c3e4c"><gtr:id>965fa2e737474be04198ec1e700c3e4c</gtr:id><gtr:otherNames>Zhao H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>doi_15744__13_236810</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3568F34C-CCFB-47B7-A865-A0D6EFB45D39</gtr:id><gtr:title>Role of necroptosis in the pathogenesis of solid organ injury.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/965fa2e737474be04198ec1e700c3e4c"><gtr:id>965fa2e737474be04198ec1e700c3e4c</gtr:id><gtr:otherNames>Zhao H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>585d5b19da2f67.64877765</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802392</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>2EEE0958-6BE1-4D16-B86B-5D954CD37219</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Renal and Urogenital</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>78E3B265-B307-4D06-9AB7-1F69471E721F</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.4  Surgery</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>